Dose-Dependent Effects of Runx2 on Bone Development
- 1 November 2009
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 24 (11), 1889-1904
- https://doi.org/10.1359/jbmr.090502
Abstract
Runx2 controls the commitment of mesenchymal cells to the osteoblastic lineage. Distinct promoters, designated P1 and P2, give rise to functionally similar Runx2-II and Runx2-I isoforms. We postulate that this dual promoter gene structure permits temporal and spatial adjustments in the amount of Runx2 isoforms necessary for optimal bone development. To evaluate the gene dose-dependent effect of Runx2 isoforms on bone development, we intercrossed selective Runx2-II(+/-) with nonselective Runx2-II(+/-)/Runx2-I(+/-) mice to create compound mutant mice: Runx2-II(+/-), Runx2-II(+/-)/Runx2-I(+/-), Runx2-II(-/-), Runx2-II(-/-)/Runx2-I(+/-), Runx2-II(-/-)/Runx2-I(-/-). Analysis of the different Runx2-deficient genotypes showed gene dose-dependent differences in the level of expression of the Runx2 isoforms. In addition, we found that Runx2-I is predominately expressed in the perichondrium and proliferating chondrocytes, whereas Runx2-II is expressed in hypertrophic chondrocytes and metaphyseal osteoblasts. Newborn mice showed impaired development of a mineralized skeleton, bone length, and widening of the hypertrophic zone that were proportionate to the reduction in total Runx2 protein expression. Osteoblast differentiation ex vivo was also proportionate to total amount of Runx2 expression that correlated with reduced Runx2 binding to the osteocalcin promoter by quantitative chromatin immunoprecipitation analysis. Functional analysis of P1 and P2 promoters showed differential regulation of the two promoters in osteoblastic cell lines. These findings support the possibility that the total amount of Runx2 derived from two isoforms and the P1 and P2 promoters, by regulating the time, place, and amount of Runx2 in response to changing environmental cues, impacts on bone development.Keywords
This publication has 86 references indexed in Scilit:
- Co-stimulation of the Bone-related Runx2 P1 Promoter in Mesenchymal Cells by SP1 and ETS Transcription Factors at Polymorphic Purine-rich DNA Sequences (Y-repeats)Journal of Biological Chemistry, 2009
- A Runx2 threshold for the cleidocranial dysplasia phenotypeHuman Molecular Genetics, 2008
- Polycystin-1 Regulates Skeletogenesis through Stimulation of the Osteoblast-specific Transcription Factor RUNX2-IIPublished by Elsevier BV ,2008
- Analysis of transcription factor interactions in osteoblasts using competitive chromatin immunoprecipitationNucleic Acids Research, 2008
- Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2Proceedings of the National Academy of Sciences of the United States of America, 2007
- Critical role of the extracellular signal–regulated kinase–MAPK pathway in osteoblast differentiation and skeletal developmentThe Journal of cell biology, 2007
- Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondriumGenes & Development, 2006
- Cilia-like Structures and Polycystin-1 in Osteoblasts/Osteocytes and Associated Abnormalities in Skeletogenesis and Runx2 ExpressionPublished by Elsevier BV ,2006
- Functional Knockout of the Matrilin-3 Gene Causes Premature Chondrocyte Maturation to Hypertrophy and Increases Bone Mineral Density and OsteoarthritisThe American Journal of Pathology, 2006
- Histone Deacetylase Inhibitors Promote Osteoblast MaturationJournal of Bone and Mineral Research, 2005